Korro Bio (KRRO) Competitors $28.65 -0.85 (-2.88%) Closing price 02/20/2025 04:00 PM EasternExtended Trading$28.78 +0.14 (+0.47%) As of 02/20/2025 06:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends KRRO vs. ETNB, GYRE, AUPH, NTLA, MRVI, ELVN, PAHC, ZYME, ABCL, and REPLShould you be buying Korro Bio stock or one of its competitors? The main competitors of Korro Bio include 89bio (ETNB), Gyre Therapeutics (GYRE), Aurinia Pharmaceuticals (AUPH), Intellia Therapeutics (NTLA), Maravai LifeSciences (MRVI), Enliven Therapeutics (ELVN), Phibro Animal Health (PAHC), Zymeworks (ZYME), AbCellera Biologics (ABCL), and Replimune Group (REPL). These companies are all part of the "pharmaceutical products" industry. Korro Bio vs. 89bio Gyre Therapeutics Aurinia Pharmaceuticals Intellia Therapeutics Maravai LifeSciences Enliven Therapeutics Phibro Animal Health Zymeworks AbCellera Biologics Replimune Group 89bio (NASDAQ:ETNB) and Korro Bio (NASDAQ:KRRO) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, community ranking, analyst recommendations, institutional ownership, media sentiment, risk and valuation. Is ETNB or KRRO more profitable? Korro Bio's return on equity of -50.25% beat 89bio's return on equity.Company Net Margins Return on Equity Return on Assets 89bioN/A -59.58% -52.21% Korro Bio N/A -50.25%-38.48% Does the media prefer ETNB or KRRO? In the previous week, 89bio had 4 more articles in the media than Korro Bio. MarketBeat recorded 4 mentions for 89bio and 0 mentions for Korro Bio. 89bio's average media sentiment score of 0.48 beat Korro Bio's score of 0.00 indicating that 89bio is being referred to more favorably in the media. Company Overall Sentiment 89bio Neutral Korro Bio Neutral Do analysts recommend ETNB or KRRO? 89bio presently has a consensus price target of $31.43, suggesting a potential upside of 186.76%. Korro Bio has a consensus price target of $144.00, suggesting a potential upside of 402.62%. Given Korro Bio's stronger consensus rating and higher probable upside, analysts clearly believe Korro Bio is more favorable than 89bio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 89bio 0 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.89Korro Bio 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.14 Which has more risk and volatility, ETNB or KRRO? 89bio has a beta of 1.17, indicating that its share price is 17% more volatile than the S&P 500. Comparatively, Korro Bio has a beta of 2.04, indicating that its share price is 104% more volatile than the S&P 500. Does the MarketBeat Community favor ETNB or KRRO? 89bio received 88 more outperform votes than Korro Bio when rated by MarketBeat users. However, 100.00% of users gave Korro Bio an outperform vote while only 64.00% of users gave 89bio an outperform vote. CompanyUnderperformOutperform89bioOutperform Votes11264.00% Underperform Votes6336.00% Korro BioOutperform Votes24100.00% Underperform VotesNo Votes Which has higher valuation & earnings, ETNB or KRRO? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio89bioN/AN/A-$142.19M-$2.91-3.77Korro BioN/AN/A-$81.17MN/AN/A Do institutionals & insiders hold more shares of ETNB or KRRO? 13.2% of Korro Bio shares are owned by institutional investors. 2.8% of 89bio shares are owned by insiders. Comparatively, 5.4% of Korro Bio shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. SummaryKorro Bio beats 89bio on 9 of the 12 factors compared between the two stocks. Get Korro Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for KRRO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KRRO vs. The Competition Export to ExcelMetricKorro BioPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$268.39M$6.98B$5.80B$9.14BDividend YieldN/A2.88%5.28%3.98%P/E RatioN/A6.1625.8619.10Price / SalesN/A303.87468.43116.08Price / CashN/A75.0445.1138.24Price / Book1.356.547.655.12Net Income-$81.17M$138.11M$3.18B$245.96M7 Day Performance-1.48%-0.47%-0.06%-0.56%1 Month Performance-22.57%1.16%3.26%0.39%1 Year Performance-48.82%-2.34%19.18%15.35% Korro Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KRROKorro Bio0.9393 of 5 stars$28.65-2.9%$144.00+402.6%-48.8%$268.39MN/A0.0070ETNB89bio3.1521 of 5 stars$10.57-1.4%$31.43+197.3%+10.8%$1.12BN/A-3.6340Analyst ForecastPositive NewsGYREGyre Therapeutics0.2412 of 5 stars$11.98+1.7%N/A-17.0%$1.12B$113.45M0.0040AUPHAurinia Pharmaceuticals2.612 of 5 stars$7.79-2.3%$11.50+47.6%+40.1%$1.12B$175.51M-51.93300Analyst DowngradeNews CoverageNTLAIntellia Therapeutics4.4217 of 5 stars$10.70+11.0%$48.71+355.2%-54.9%$1.09B$36.28M-1.97600Gap UpMRVIMaravai LifeSciences4.065 of 5 stars$4.20+1.9%$10.28+144.8%-25.8%$1.06B$288.95M-2.56610Options VolumeNews CoverageELVNEnliven Therapeutics1.9877 of 5 stars$21.68+0.8%$38.25+76.4%+29.6%$1.06BN/A-11.4150PAHCPhibro Animal Health3.9375 of 5 stars$25.77+2.3%$21.00-18.5%+88.0%$1.04B$1.02B53.691,940High Trading VolumeZYMEZymeworks2.3702 of 5 stars$15.01+2.7%$19.17+27.7%+16.4%$1.03B$76.01M-10.01460ABCLAbCellera Biologics2.7655 of 5 stars$3.27+4.1%$8.33+154.8%-40.9%$965.86M$38.03M-5.36500Upcoming EarningsREPLReplimune Group4.2234 of 5 stars$14.10-1.3%$19.29+36.8%+87.1%$964.72MN/A-4.62210 Related Companies and Tools Related Companies 89bio Alternatives Gyre Therapeutics Alternatives Aurinia Pharmaceuticals Alternatives Intellia Therapeutics Alternatives Maravai LifeSciences Alternatives Enliven Therapeutics Alternatives Phibro Animal Health Alternatives Zymeworks Alternatives AbCellera Biologics Alternatives Replimune Group Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:KRRO) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Korro Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Korro Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KRRO Stock Alerts